Core Viewpoint - The announcement from Huahao Zhongtian Pharmaceutical-B (02563) pertains to the redemption of subscriptions for the LFM Stable Income Fund SP, following a court ruling in the Cayman Islands that appointed a liquidator for the sub-fund [1] Group 1 - The Grand Court of the Cayman Islands (Financial Services Division) issued a judgment on December 3, 2025, approving the company's application to appoint a liquidator for the sub-fund [1] - The court recognized US-Biostar as a creditor based on the terms of the subscription agreement [1] - The company's legal advisors have communicated with the appointed liquidator, who will initiate the liquidation and takeover process for the LFM Fund under Cayman Islands law [1] Group 2 - The company contacted the liquidator on December 10, 2025, to advance the takeover process [1]
华昊中天医药-B(02563)：法院批准公司委任接管人接管子基金的申请 公司已联系接管人以推进接管程序